Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01387750
Other study ID # RCTS2223
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received June 30, 2011
Last updated July 5, 2011
Start date May 2007
Est. completion date June 2007

Study information

Verified date June 2011
Source NEMA Research, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

A single center trial to evaluate the efficacy, tolerance, and acceptability of Oxygenated Glycerol Triesters (OGT) mentholated cream on acute musculoskeletal pain in normal healthy adult volunteers suffering from a recent inflammation of muscles and joints. Patient who met eligibility requirements were instructed to identify one area on their body where they were experiencing the most acute musculoskeletal pain/discomfort. Patients were provided with visual analog scales in order to quantify their pain. Patients either received mentholated cream with or without OGT and instructed to rub on the identified site 3 times a day for 7 days. Pain and other observations were written in a diary for each day.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date June 2007
Est. primary completion date June 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

1. Were males and females between the ages of 18 and 75, in good general health (no physical required but subjects did fill out a medical history questionnaire)

2. Were individuals free of any systemic or dermatological disorder including a known history of allergies or other medical conditions which, in the opinion of the investigator, might have interfered with the conduct of the study, interpretation of results or increased the risk of adverse reactions;

3. Were individuals that had recently (< three months) started to suffer from acute musculoskeletal pain (i.e. arthritis, simple back pain, muscle strains);

4. Agreed to stop any anti-inflammatory or analgesic medications two days prior to starting the study;

5. Had the ability to complete the course of the study and to comply with instructions;

6. Agreed not to use or introduce any new personal care products (including cosmetics, skin care, hand care, body care, hair care, personal hygiene, etc.) into their normal regimen during the course of the study;

7. Agreed to avoid sun exposure during the course of the study;

8. Were females that were surgically sterile, post-menopausal or using an acceptable method of birth control; and

9. Were able to read, understand and provide written informed consent.

Exclusion Criteria:

1. Were individuals with any visible skin disease or skin condition (e.g., eczema), which might have interfered with the evaluations;

2. Were individuals with excessive dryness or redness at the sites of application;

3. Were individuals who suffered from chronic and/or severe musculoskeletal pain;

4. Were individuals with a known hypersensitivity to topical analgesics or other pain relieving products;

5. Were females who were pregnant, planning a pregnancy or nursing a child;

6. Were individuals who were participating, or had participated, on a clinical study involving the body (exclusive of the face) within 28 days prior to study initiation;

7. Were individuals who had psoriasis;

8. Were individuals currently under treatment for asthma or diabetes (insulin-dependent only);

9. Were individuals with active atopic dermatitis/eczema at the test sites;

10. Were individuals taking prescription or over-the-counter anti-inflammatory medications, non- steroidal anti-inflammatory drugs and topical, oral and systemic steroids; and

11. Were individuals with known allergies to any of the components of the test articles.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Mentholated Cream
A topical cream containing menthol without the addition of the oxygenated glycerol triesters.
Mentholated Cream with OGT
A Topical Cream that contained both menthol and oxygenated glycerol triesters.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
NEMA Research, Inc. Laboratories Carilene

Outcome

Type Measure Description Time frame Safety issue
Primary Severity of Pain Patients were instructed to identify one area on their body where they were experiencing the most acute musculoskeletal pain/discomfort. No
Secondary Limitation of Activity How limited patient activities were due to the pain associated with the area of interest. No
Secondary Evaluation of the mobility of the painful joint/muscle Patient assessed how mobile their joints/muscles were within the area of interest. No
Secondary Skin Toxicity Tolerability was assessed from Redness and Dryness VAS recorded by the clinical evaluator. No formal safety testing was performed in this study; however anecdotal information (stinging, burning, itching, etc.) was captured on the subjects' diaries. Yes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care